Art. 42 Regulation (EU) 2017/745

Designation and notification procedure

In forcesince 5 Apr 2017cited 8×
1.

Member States may only designate conformity assessment bodies for which the assessment pursuant to Article 39 was completed and which comply with Annex VII.

2.

Member States shall notify the Commission and the other Member States of the conformity assessment bodies they have designated, using the electronic notification tool within the database of notified bodies developed and managed by the Commission (NANDO).

3.

The notification shall clearly specify, using the codes referred to in paragraph 13 of this Article, the scope of the designation indicating the conformity assessment activities as defined in this Regulation and the types of devices which the notified body is authorised to assess and, without prejudice to Article 44, any conditions associated with the designation.

4.

The notification shall be accompanied by the final assessment report of the authority responsible for notified bodies, the final opinion of the joint assessment team referred to in Article 39(9) and the recommendation of the MDCG. Where the notifying Member State does not follow the recommendation of the MDCG, it shall provide a duly substantiated justification.

5.

The notifying Member State shall, without prejudice to Article 44, inform the Commission and the other Member States of any conditions associated with the designation and provide documentary evidence regarding the arrangements in place to ensure that the notified body will be monitored regularly and will continue to satisfy the requirements set out in Annex VII.

6.

Within 28 days of the notification referred to in paragraph 2, a Member State or the Commission may raise written objections, setting out its arguments, with regard either to the notified body or to its monitoring by the authority responsible for notified bodies. Where no objection is raised, the Commission shall publish in NANDO the notification within 42 days of its having been notified as referred to in paragraph 2.

7.

When a Member State or the Commission raises objections in accordance with paragraph 6, the Commission shall bring the matter before the MDCG within 10 days of the expiry of the period referred to in paragraph 6. After consulting the parties involved, the MDCG shall give its opinion at the latest within 40 days of the matter having been brought before it. Where the MDCG is of the opinion that the notification can be accepted, the Commission shall publish in NANDO the notification within 14 days.

8.

Where the MDCG, after having been consulted in accordance with paragraph 7, confirms the existing objection or raises another objection, the notifying Member State shall provide a written response to the MDCG opinion within 40 days of its receipt. The response shall address the objections raised in the opinion, and set out the reasons for the notifying Member State's decision to designate or not designate the conformity assessment body.

9.

Where the notifying Member State decides to uphold its decision to designate the conformity assessment body, having given its reasons in accordance with paragraph 8, the Commission shall publish in NANDO the notification within 14 days of being informed thereof.

10.

When publishing the notification in NANDO, the Commission shall also add to the electronic system referred to in Article 57 the information relating to the notification of the notified body along with the documents mentioned in paragraph 4 of this Article and the opinion and responses referred to in paragraphs 7 and 8 of this Article.

11.

The designation shall become valid the day after the notification is published in NANDO. The published notification shall state the scope of lawful conformity assessment activity of the notified body.

12.

The conformity assessment body concerned may perform the activities of a notified body only after the designation has become valid in accordance with paragraph 11.

13.

The Commission shall by 26 November 2017, by means of implementing acts, draw up a list of codes and corresponding types of devices for the purpose of specifying the scope of the designation of notified bodies. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 114(3). The Commission, after consulting the MDCG, may update this list based, inter alia, on information arising from the coordination activities described in Article 48.

  • Order of the General Court (Sixth Chamber) of 23 May 2023. Atesos medical AG and Others v European Commission.Decision

    Articles 35 to 50 of Regulation 2017/745 relating to notified bodies are therefore applicable to the applicants’ situation.

    23 May 2023 · 62021TO0764(01)

  • MPDG17aLaw

    … für Benannte Stellen zuständigen Behörde. (2) Hat ein anderer Mitgliedstaat eine Konformitätsbewertungsstelle nach Artikel 42 der Verordnung (EU) 2017/745 oder Artikel 38 der Verordnung (EU) 2017/746 notifiziert, entscheidet die für …

  • The Medical Devices (Northern Ireland Protocol) Regulations 202119Law

    … 2017/745 or Article 42(1) of Regulation (EU) 2017/746. (3) A notified body designated by the Secretary of State under Article 42 of Regulation (EU) 2017/745 that submits a summary evaluation report to the Secretary of State in accordance …

  • Medizinproduktegesetz 202183Law

    … Produkte verantwortlich, es sei denn, der Hersteller ist mit einer Benannten Stelle, deren Benennung gemäß Art. 42 der Verordnung (EU) Nr. 745/2017 erfolgt ist, übereingekommen, dass sie eine derartige Überwachung durchführt. (6a) Die …

  • Regulation (EU) 2017/2185Law

    … 1.], and in particular Articles 39(10) and 42(13) thereof, Having regard to Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and …

  • Order of the Court (Seventh Chamber) of 11 April 2024. Atesos medical AG and Others v European Commission and Others.Decision

    In the second place, in paragraphs 40 and 41 of the order under appeal, the General Court held that Articles 35 to 50 of Regulation 2017/745 are applicable to the appellants’ situation.

    11 Apr 2024 · 62023CO0491

  • Order of the General Court (Sixth Chamber) of 23 May 2023. Atesos medical AG and Others v European Commission.Decision

    23 May 2023 · 62021TO0764(01)

  • MPDG17aLaw